Long COVID MCAS: Understanding Mast Cell Activation After Infection
What Is Long COVID MCAS?
If you've developed flushing, hives, stomach upset, a racing heart or new food reactions since having COVID, you may have come across the term Long COVID MCAS. It describes mast cell activation symptoms that appear or worsen after a SARS-CoV-2 infection. Mast cell activation is increasingly discussed in people living with Long COVID. For many people, putting a name to these confusing, shifting symptoms is a real relief.
This article explains what mast cells do, why they might become overactive after an infection, how this overlaps with POTS and histamine intolerance, and which genes research has started to explore. It is informational only and is meant to support better conversations with your healthcare professional.
How Mast Cell Activation Works
Mast cells in plain English
Mast cells are immune cells that sit in tissues that face the outside world, such as your skin, gut, airways and the lining of blood vessels. They act as early-warning sentries. When they sense a threat, they release chemical messengers, called mediators, to raise the alarm.
The best-known mediator is histamine. Histamine widens blood vessels, makes them leakier, stimulates the gut and can trigger itching. In a short burst, this is helpful. It brings immune cells to the area and helps flush out an invader.
Mast Cell Activation Syndrome describes a situation where mast cells release these mediators too easily, too often or too strongly, even when no real threat exists. Because mast cells live in so many tissues, the symptoms can show up almost anywhere in the body:
- Skin: flushing, itching, hives
- Gut: bloating, cramps, diarrhoea, nausea
- Heart and circulation: palpitations, lightheadedness, blood pressure swings
- Brain: headaches, brain fog, poor sleep
- Airways: congestion, wheeze, throat tightness
Why it may start after COVID
Researchers are still working out why mast cell problems may begin after COVID, and several ideas are being explored. A viral infection is a major immune event. Mast cells take part in that response, and in some people they may not fully "stand down" afterwards.
Ongoing inflammation is one possible driver. Some of the immune signals that stay raised after an infection are the same signals that help mast cells survive, multiply and become more reactive. Research suggests this could create a cycle in which inflammation keeps mast cells primed and mast cell mediators feed more inflammation. Changes in gut bacteria after infection may also add to the histamine load. Genetic differences in how the body makes and clears histamine may then shape how strongly a person feels these effects.
The overlap with histamine intolerance
Histamine intolerance and MCAS are related but not identical. In MCAS, the main problem is that mast cells release too much histamine and other mediators. In histamine intolerance, the main problem is that the body clears histamine too slowly, especially histamine from food. The symptoms can look almost the same, and both may be present at once. A person with slightly sluggish histamine breakdown may cope well until an infection pushes their mast cells into overdrive, and then the combined load becomes noticeable.
The overlap with POTS
POTS (postural orthostatic tachycardia syndrome) involves a large rise in heart rate on standing, often with dizziness, fatigue and brain fog. It is also commonly reported after COVID. Histamine widens blood vessels, which can make it harder for the body to keep blood flowing to the brain when upright. This is one reason clinicians and researchers have looked at whether mast cell activity and POTS may influence each other in some people. Many people with Long COVID describe features of both, along with histamine intolerance, and the three can be hard to separate.
Genes and Variants Linked to Mast Cell Activity
Studies have explored several genes involved in making histamine, breaking it down and controlling how mast cells behave. Having a particular variant does not mean you will develop MCAS. These findings are best seen as pieces of a much larger puzzle.
Breaking histamine down: AOC1 and HNMT
The AOC1 gene encodes the enzyme diamine oxidase, often shortened to DAO. You may also see it discussed on our DAO page. This enzyme works in the gut lining and is the main defence against histamine from food. Research suggests that variants such as rs10156191, rs2052129 and rs1049742 may reduce its activity, which is linked to dietary histamine intolerance. In Long COVID, reduced AOC1 function combined with gut changes and higher histamine release may add to histamine-driven symptoms.
HNMT handles histamine inside cells, and it is the main breakdown route in the airways and the brain. The Thr105Ile variant, rs11558538, has been reported to cut enzyme activity by roughly half. Studies have explored how slower histamine clearance through HNMT, together with extra mast cell histamine release, may relate to headaches, flushing, palpitations and gut symptoms.
Making histamine: HDC
HDC produces the enzyme that turns the amino acid histidine into histamine. It is the only known route for making histamine in the body. Variants such as rs2071577 may affect how quickly histamine is produced. Researchers have suggested that the balance between HDC on the production side and HNMT and AOC1 on the clearance side may help shape a person's overall histamine load.
Mast cell sensitivity and survival: MS4A2, KITLG and IL9
MS4A2 encodes part of the high-affinity IgE receptor on mast cells, which amplifies allergy-type signals. Variants such as rs569108 have been associated with a higher tendency towards atopic conditions and may affect how sensitive mast cells are.
KITLG encodes stem cell factor, a key signal that keeps mast cells alive and resident in tissues. Raised stem cell factor in inflammatory states may help keep mast cells chronically activated, which is one theory for persistent symptoms after infection.
IL9 encodes interleukin-9, an immune messenger that activates mast cells. Variants such as rs31563 may influence mast cell sensitivity.
A mast cell marker: CPA3
CPA3 encodes an enzyme released specifically when mast cells degranulate. Elevated CPA3 levels have been reported in some people with Long COVID, which supports the idea of mast cell involvement. Variants such as rs7289261 may affect how much of this enzyme is produced.
Practical Implications
Understanding the possible biology behind Long COVID MCAS can make your symptoms feel less random. It can also help you have more focused conversations with your care team.
Some general points to keep in mind:
- Patterns matter more than single genes. A variant in one histamine gene is common and usually has a modest effect. Several variants across making, clearing and responding to histamine may tell a richer story.
- Keep a symptom diary. Noting foods, activities, temperature changes, stress and posture alongside symptoms can help you and your clinician spot triggers.
- Bring information, not conclusions. Genetic results can add context, but they cannot confirm MCAS, histamine intolerance or POTS. Proper assessment needs clinical history, examination and sometimes specialist testing.
- Avoid big changes on your own. Restrictive diets or new products can have downsides. Discuss any changes with a qualified healthcare professional first.
- Be patient with the science. Research into mast cells and Long COVID is still emerging, and our understanding is likely to keep evolving.
Living with unpredictable reactions is exhausting. Learning how your body may handle histamine is one step towards feeling more informed and more in control.
Get Personalized DNA Insights
If you have consumer DNA data, ChronicDNA can show you which variants you carry in histamine and mast cell genes such as AOC1, HNMT, HDC and MS4A2. Your report explains each result in plain language, so you can bring clear, organised information to your healthcare professional.